Showing results (291-300 of 426) with videos related to
Sort By:
Pageof 43
The American Journal of Cardiology|December 26, 2015
Torsemide Versus Furosemide in Patients With Acute Heart Failure (from the ASCEND-HF Trial)Robert J Mentz, Vic Hasselblad, Adam D DeVore, et al.Circulation. Heart Failure|July 28, 2023
Evolution of NT-proBNP During Prerandomization Screening in VICTORIA: Implications for Clinical Outcomes and Efficacy of VericiguatPaul W Armstrong, Yinggan Zheng, Lars H Lund, et al.American Heart Journal|November 13, 2022
Rationale and design of the Aldose Reductase Inhibition for Stabilization of Exercise Capacity in Heart Failure Trial (ARISE-HF) in patients with high-risk diabetic cardiomyopathyJames L Januzzi, Javed Butler, Stefano Del Prato, et al.Journal of the American Heart Association|February 13, 2018
Interaction of Body Mass Index on the Association Between N-Terminal-Pro-b-Type Natriuretic Peptide and Morbidity and Mortality in Patients With Acute Heart Failure: Findings From ASCEND-HF (Acute Study of Clinical Effectiveness of Nesiritide in Decompensated Heart Failure)Ankeet S Bhatt, Lauren B Cooper, Andrew P Ambrosy, et al.Circulation|July 31, 2014
Nesiritide, renal function, and associated outcomes during hospitalization for acute decompensated heart failure: results from the Acute Study of Clinical Effectiveness of Nesiritide and Decompensated Heart Failure (ASCEND-HF)Vincent M van Deursen, Adrian F Hernandez, Amanda Stebbins, et al.JACC. Heart Failure|October 25, 2025
Functional and Prognostic Implications of Different Iron Deficiency Definitions in Heart Failure: Insights From HEART-FIDGregory D Lewis, Anna Giczewska, Robert J Mentz, et al.European Heart Journal. Cardiovascular Pharmacotherapy|February 19, 2021
Cardiac and cardiometabolic phenotyping of trastuzumab-mediated cardiotoxicity: a secondary analysis of the MANTICORE trialAmy A Kirkham, Edith Pituskin, Richard B Thompson, et al.Trials|February 6, 2021
Management of Renin-Angiotensin-Aldosterone System blockade in patients admitted to hospital with confirmed coronavirus disease (COVID-19) infection (The McGill RAAS-COVID- 19): A structured summary of a study protocol for a randomized controlled trialMona Aflaki, Alexandria Flannery, João Pedro Ferreira, et al.ESC Heart Failure|September 27, 2021
Cardiac remodelling predicts outcome in patients with chronic heart failureLingyu Xu, Joseph Pagano, Kelvin Chow, et al.ESC Heart Failure|November 16, 2021
The influence of comorbidities on achieving an N-terminal pro-b-type natriuretic peptide target: a secondary analysis of the GUIDE-IT trialJustin A Ezekowitz, Wendimagegn Alemayehu, Sarah Rathwell, et al.Pageof 43